Research Highlights

Pages Tagged with "Research Highlights"

City of Hope researchers present innovative studies at American Society of Hematology meeting
Doctors and scientists from City of Hope presented data on potential new treatment options for hematological cancers and a way to predict disease outcomes in patients with diffuse large B-cell...
World Health Day and City of Hope: Committed to a better future
World Health Day, celebrated annually on April 7, marks the anniversary of the founding of the World Health Organization (WHO). This year’s goal is to “focus global attention on...
New grant awarded to City of Hope researchers seeks to advance glioblastoma treatment
Behnam Badie, M.D.City of Hope’s Brain Tumor Program is constantly looking at ways to improve care in the field of neurological cancers by combining innovative research with expert...
Our world-class experts shared experimental therapy findings, promising immunotherapy efficacy and genetic-based insights for improved survival
Over the first week in June, premier oncology researchers from City of Hope gathered virtually at the American Society of Clinical Oncology Annual meeting with experts from around the world...
Ongoing breast cancer research focused on treatment-related infections and CAR T therapy
Breast Cancer Research Team Reports Infection Trend in Ongoing Clinical Trial That Has Implication on Current Treatments City of Hope is currently conducting an ongoing clinical trial exploring the trend...
Our world-class experts share novel treatment approaches, innovative CAR T cell therapies and epidemiologic insights for cancer
From April 10 to 15, the brightest minds in the field of oncology and medicine will gather for the first week of this year’s all-virtual AACR Annual Meeting. The...
Delivering CAR T cell target CD19 onto the surface of solid tumors with a genetically engineered oncolytic virus
Overcoming CAR T cell therapy limitations to treat solid tumor cancersBy genetically engineering a tumor-selective oncolytic virus to deliver the surface antigen CD19 for expression on solid tumor...
Investigating the FDA-approved rheumatoid arthritis drug leflunomide as a treatment option for COVID-19 in patients with cancer
The expertise at City of Hope has allowed investigators to quickly begin exploration and development of new treatment options to combat the novel SARS-CoV-2 virus.   Working toward this goal,...
New therapeutic research strategies to combat COVID-19
As the total number of COVID-19 cases continues to rise in the U.S., our renowned physician-scientists are taking numerous research approaches to swiftly work toward scientific answers needed to combat...
Is this next-generation T cell therapy the answer for patients with relapsed or refractory multiple myeloma?
The physician-scientists at City of Hope who see one of the highest volumes of patients with multiple myeloma in Southern California have firsthand knowledge of the unmet treatment needs...